Novo Nordisk

Novo Nordisk is a global healthcare company specializing in diabetes care, obesity, and other serious chronic diseases. They generate revenue primarily through the development, production, and sale of pharmaceutical products and services, particularly insulin and GLP-1 receptor agonists. Founded in 1923 and headquartered in Denmark, Novo Nordisk has a rich history of innovation in diabetes treatment and a strong commitment to sustainability and social responsibility.

Recent Posts by Novo Nordisk

1-20 of 366